(19)

(11)

EP 3 691 656 A1

(12)

(43) Date of publication: 12.08.2020 Bulletin 2020/33 (21) Application number: 18797262.5 (22) Date of filing: 09.10.2018

(51) International Patent Classification (IPC):  A61K 31/713(2006.01) A61K 31/395(2006.01) A61K 31/4418(2006.01) A61K 31/519(2006.01) A61K 31/5377(2006.01) A61P 3/00(2006.01) A61K 31/4375(2006.01) A61K 31/506(2006.01) A61K 31/52(2006.01) A61K 31/5513(2006.01) (86) International application number: PCT/US2018/055087 (87) International publication number: WO 2019/071276 (11.04.2019 Gazette 2019/15)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 06.10.2017 US 201762568893 P (71) Applicant: Camp4 Therapeutics Corporation Cambridge, MA 02139 (US)	(72) Inventors: SEHGAL, Alfica Cambridge MA 02139 (US) SIGOVA, Alla, A. Cambridge MA 02139 (US) ZLOBINE, Igor Cambridge MA 02139 (US) SCHWARTZ, Brian, E. Cambridge MA 02139 (US) BUMCROT, David, A. Cambridge MA 02139 (US) (74) Representative: Elkington and Fife LLP  Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR Sevenoaks, Kent TN13 1XR (GB)